We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

SARM1: A Potential Drug Target for Parkinson's and Alzheimer's Disease

News   Mar 04, 2021 | Original story from the University of Queensland

 
SARM1: A Potential Drug Target for Parkinson's and Alzheimer's Disease

An artist's impression of the brain, made from images of the SARM1 protein. Credit: The University of Queensland

 
 
Advertisement
 

RELATED ARTICLES

UK Government-Funded COVID-19 Vaccine Phase 1/2 Trials Report Positive Data

News

A new COVID-19 vaccine candidate – VLA2001 – developed by Valneva has shown positive results in a UK Government-funded Phase I/II clinical trial, according to a press release.

READ MORE

Molecular Devices Opens Organoid Innovation Center

News

Molecular Devices, LLC., has opened an Organoid Innovation Center at the company’s global headquarters. The center expands beyond imaging to demonstrate an end-to-end solution that addresses challenges associated with every step in the sample prep-to-report pipeline for assays performed on complex 3D biological models.

READ MORE

ALS Finding Links Blood and Brain

News

Researchers have examined a type of cell in the brain blood vessels that could explain the unpredictable origins and dynamics of ALS. The results indicate a previously unknown connection between the nervous and vascular systems.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE